Kenyon Sweeney

Kenyon Sweeney serves as the Chief Commercial Officer at Agendia since 2022. Prior experience includes a role as Vice President of Commercial at Adaptive Biotechnologies Corp., where Kenyon led the launch of T-Detect and achieved significant revenue growth. At Myriad Genetics, Kenyon held multiple positions, culminating in Vice President of Sales, driving substantial revenue through the GeneSight test, and Vice President of Commercial Operations, overseeing a major operational transformation. Early career at Sanofi involved various roles in sales management. Kenyon holds an MBA in Entrepreneurship from Westminster University and a BA in Communications from Taylor University, along with education from the Quinlan School of Business at Loyola University Chicago.